Development asset linked to Dianthus Therapeutics, Inc in public FDA and regional records.
pharma · Chronic Inflammatory Demyelinating Polyneuropathy · Multifocal Motor Neuropathy · DNTH
Dianthus Therapeutics, Inc
Dianthus Therapeutics, Inc. /DE/
Dianthus Therapeutics, Inc drug portfolio — 12 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
New York City, USA HQ
111 Employees
Public company Type
DNTH · NYSE Ticker
Company details
- Status
- Public
- HQ
- New York City, USA
- Employees
- 111
- Programs
- 6
- Drugs
- 12
- Patents
- 2
Dianthus Therapeutics, Inc pipeline
Portfolio lens on 12 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Dianthus Therapeutics, Inc drug portfolio — 12 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Dianthus Therapeutics, Inc in public FDA and regional records.
-
Development asset linked to Dianthus Therapeutics, Inc in public FDA and regional records.
-
Development asset linked to Dianthus Therapeutics, Inc in public FDA and regional records.
-
meningococcal group b vaccine (rdna, component, adsorbed)
Antiinfectives for systemic use (J07)Antiinfectives for systemic use (J07) compound in Dianthus Therapeutics, Inc's portfolio.
-
meningococcal groups a, c, w-135 and y conjugate vaccine
Antiinfectives for systemic use (J07)Antiinfectives for systemic use (J07) compound in Dianthus Therapeutics, Inc's portfolio. Mechanism: Immunostimulant.
- Mechanism
- Immunostimulant
-
Development asset linked to Dianthus Therapeutics, Inc in public FDA and regional records.
-
Development asset linked to Dianthus Therapeutics, Inc in public FDA and regional records.
-
Development asset linked to Dianthus Therapeutics, Inc in public FDA and regional records.
-
Development asset linked to Dianthus Therapeutics, Inc in public FDA and regional records.
-
Development asset linked to Dianthus Therapeutics, Inc in public FDA and regional records.
-
Development asset linked to Dianthus Therapeutics, Inc in public FDA and regional records.